Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Drug:  liposomal daunorubicin citrate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-5 of 5 for your search:
Start Over
Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia
Phase: Phase III
Type: Treatment
Status: Completed
Age: 17 and under
Sponsor: Other
Protocol IDs: TRIAL, TRIAL Relapsed AML 2001/01, NCT00186966
Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02329, ID99-341, CDR0000067822, MDA-ID-99341, NCI-673, 673, NCT00005942
Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067944, E-4999, NCT00005962
Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000067453, LRI-103-UK-V1.1, EU-99033, NCT00004207
Start Over